Narrow Results

Artus Acquires Global Broad PCR License.

US Food Regulatory Regime Draws Criticism for Mad Cow Scare.

The article is about complementary and alternative medicine in United States. It touches on the brief history of alternative medicine in US and the clinical use, research, education and the legislature and license of alternative medicine in the US.

The article touches on the intellectual property rights and protecting licensing issues.

License for the Release of Genetically Modified Salt-Tolerant Wheat.

GM Rice with Human Gene is More Herbicide-Resistant.

Forum boosts Queensland-China research partnerships.

Taiwan researchers develop stress-releasing lactic fermented drink.

Salt cress genome yields new clues to salt tolerance.

Shanghai scientists may have found AIDS vaccine.

Improved production of Acetone–Butanol–Ethanol (ABE) by genome shuffling of Clostridium acetobutylicum CICC 8012.

BGI debuts new tool "PDXomics™" for tumor xenograft research and applications.

New study sheds light on the niche divergence between related ungulates at large scale.

MoU signed between PAS, CAS to enhance scientific cooperation.

RegeneRx and Lee's reach license agreement for TB4-based products.

Cognoptix licenses AD detection technology.

3D cell culture firm Reinnervate and specialist Oncology CRO Oncotest GmbH enter collaboration agreement.

Medicago awarded contract from the U.S. Department of Defence.

Clinical Network Services acquires New Zealand partner BELTAS' business assets.

VABIOTECH licenses cell-based Japanese encephalitis technology from Inviragen.

University of Illinois licenses novel anti-cancer therapies to StemPar Sciences.

Adimab announces new discovery collaboration with Kyowa Hakko Kirin.

Priaxon enters collaboration with GSK on protein-protein-interactions.

Lantheus Medical Imaging and FUJIFILM RI Pharma renew long-term license and distribution agreement.

When an outside innovating firm has a cost-reducing technology, it can sell licenses of its technology to incumbent firms, or enter the market and at the same time sell licenses, or enter the market without license. We examine the definitions of license fees in such situations under oligopoly, one outside innovating firm and several incumbent firms, considering threat by entry by the innovating firm using a two-step auction.